Home > Animal Health & Nutrition > Veterinary Services > Veterinary Eye Care Market

Veterinary Eye Care Market Trends

Report ID: GMI8499
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Veterinary Eye Care Market Trends

Rising incidence of eye disorders in pets is a significant driver of the veterinary eye care industry. For instance, as per a study published in the MSD Veterinary Manual, glaucoma is a significant concern in dogs, affecting nearly 2% of dogs in North America, with some breeds having a higher incidence rate than others.
Factors such as genetics, age, environmental factors, and underlying health conditions such as diabetes can contribute to the development of these disorders.
Further, as more people embrace pets as integral members of their families, the demand for comprehensive veterinary services, including eye care, has risen.
Additionally, pet owners are becoming more aware of the importance of preventive care, leading to regular eye examinations and early detection of potential issues. This trend has fueled the growth of the market, prompting advancements in diagnostic tools and treatments tailored to animal’s unique ocular needs.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of veterinary eye care was worth USD 67.4 billion in 2023 and is set to expand at 3.5% CAGR over 2024-2032, driven by the increasing awareness among pet owners about the importance of eye health in animals leading to a higher demand for diagnostic and therapeutic eye care products.

The product segment reached USD 43.9 billion in revenue in 2023, owing to the rising awareness among pet owners regarding the importance of eye health in animals and the increasing prevalence of eye disorders in pets.

North America market held 43.4% revenue share in 2023 and is set to reach USD 39 billion by 2032, attributed to the advanced healthcare infrastructure, robust veterinary services, and a high level of pet adoption in the region.

Major firms in the market are An-Vision GmbH, Bausch & Lomb Inc., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, IRIDEX Corporation, I-Med Animal Health, LKC Technologies, Inc., Neuronix Ltd., OptoMed, Reichert, Inc., and Zoetis Services LLC.